Michelle A. Lifton focuses on Virology, Immunology, Immune system, Virus and Immunity. The concepts of her Virology study are interwoven with issues in Vector, CTL* and Immunogenicity. Her studies deal with areas such as Viremia and Adenoviridae as well as Immunity.
Her Viremia research integrates issues from Cellular immunity and Vaccinia. Her Simian immunodeficiency virus research is multidisciplinary, relying on both Immunoglobulin G, DNA vaccination and T cell. Her Epitope research is multidisciplinary, incorporating perspectives in T lymphocyte and Serotype.
Michelle A. Lifton mostly deals with Virology, Immunology, Simian immunodeficiency virus, Immune system and Virus. Michelle A. Lifton interconnects CTL*, Cytotoxic T cell, CD8, Immunogenicity and Epitope in the investigation of issues within Virology. Michelle A. Lifton has included themes like Modified vaccinia Ankara, Viral replication and Lentivirus in her Simian immunodeficiency virus study.
Her Immune system research includes themes of Antigen and Rhesus macaque. Her work deals with themes such as Interleukin 2, Vaccinia and Lymphocyte, which intersect with Virus. Michelle A. Lifton interconnects Measles vaccine and Adenoviridae in the investigation of issues within Immunity.
Her primary areas of study are Immunology, Virology, Simian immunodeficiency virus, Vaccination and Immunogenicity. In the field of Immunology, her study on Immune system, Rhesus macaque and Tumor necrosis factor alpha overlaps with subjects such as Bronchoalveolar lavage. The Virology study combines topics in areas such as Cd4 t cell, Ex vivo and Antibody.
Her Antibody study combines topics from a wide range of disciplines, such as Immunity and Antigen. Her Simian immunodeficiency virus study is concerned with the field of Virus as a whole. Her work carried out in the field of Vaccination brings together such families of science as Cytotoxic T cell and Immunization.
The scientist’s investigation covers issues in Immunology, Antibody, Virology, Immune system and Antigen. Her ELISPOT, Simian immunodeficiency virus and Zika virus study, which is part of a larger body of work in Immunology, is frequently linked to Pneumonia, bridging the gap between disciplines. Her ELISPOT research is multidisciplinary, relying on both Epitope, Immunogen and Immunogenicity.
Her Simian immunodeficiency virus study is concerned with the larger field of Virus. Her studies in Zika virus integrate themes in fields like Viral Vaccine, Vaccination, Neutralizing antibody and Immunization. Her biological study spans a wide range of topics, including Ex vivo and In vivo.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Control of Viremia in Simian Immunodeficiency Virus Infection by CD8+ Lymphocytes
Jörn E. Schmitz;Marcelo J. Kuroda;Sampa Santra;Vito G. Sasseville.
Science (1999)
Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity.
John W. Shiver;Tong-Ming Fu;Ling Chen;Danilo R. Casimiro.
Nature (2002)
Control of Viremia and Prevention of Clinical AIDS in Rhesus Monkeys by Cytokine-Augmented DNA Vaccination
Dan H. Barouch;Sampa Santra;Jörn E. Schmitz;Marcelo J. Kuroda.
Science (2000)
Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes
Dan H. Barouch;Jennifer Kunstman;Marcelo J. Kuroda;Jörn E. Schmitz.
Nature (2002)
Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity
Diane M. Roberts;Anjali Nanda;Menzo J. E. Havenga;Peter Abbink.
Nature (2006)
SARS-CoV-2 infection protects against rechallenge in rhesus macaques.
Abishek Chandrashekar;Jinyan Liu;Amanda J. Martinot;Amanda J. Martinot;Katherine McMahan.
Science (2020)
Immunogenicity of Recombinant Adenovirus Serotype 35 Vaccine in the Presence of Pre-Existing Anti-Ad5 Immunity
Dan H. Barouch;Maria G. Pau;Jerome H. H. V. Custers;Wouter Koudstaal.
Journal of Immunology (2004)
Emergence of CTL coincides with clearance of virus during primary simian immunodeficiency virus infection in rhesus monkeys.
Marcelo J. Kuroda;Jörn E. Schmitz;William A. Charini;Christine E. Nickerson.
Journal of Immunology (1999)
Neutralizing Antibodies to Adenovirus Serotype 5 Vaccine Vectors Are Directed Primarily against the Adenovirus Hexon Protein
Shawn M. Sumida;Diana M. Truitt;Angelique A. C. Lemckert;Ronald Vogels.
Journal of Immunology (2005)
Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination
Norbert Pardi;Michael J. Hogan;Rebecca S. Pelc;Hiromi Muramatsu.
Nature (2017)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Beth Israel Deaconess Medical Center
Beth Israel Deaconess Medical Center
Beth Israel Deaconess Medical Center
Beth Israel Deaconess Medical Center
Duke University
University of Massachusetts Medical School
United States Military Academy
Bernhard Nocht Institute for Tropical Medicine
Bernhard Nocht Institute for Tropical Medicine
Harvard University
Indian Institute of Science
University of Oxford
University of California, Los Angeles
Forschungszentrum Jülich
Spanish National Research Council
University of Georgia
University of Tokyo
University of California, San Diego
Chinese Academy of Sciences
Sorbonne University
University Hospital of Basel
University of Parma
Oregon Health & Science University
University of Pennsylvania